Virus engineering and nanobiotechnology
Dr. Mauricio García Mateu. Catedrático. Departamento de Biología Molecular. UAM.
Dr. Alejandro Valbuena Jiménez. Profesor Ayudante Doctor. Departamento de Biología Molecular. UAM.
Major research goals: We use protein engineering techniques and biochemical, biophysical and virological analyses to study assembly, conformational stability and dynamics and physical properties of viruses, and their biological relevance (Mateu (ed.) (2013) Structure and Physics of Viruses, Springer 2013; Mateu (2013) Arch.Biochem.Biophys. 531,65-79). Based on these studies, we aim also at the design and analysis of genetically and/or structurally modified viral particles for the development of biomedical and bionanotechnological applications (Mateu (2016). In Protein-based Engineered Nanostructures, Springer 2016, pp.83-120).
Scientific relevance and technological implications: In-depth knowledge of certain key processes for viral infection, including virus morphogenesis, structural rearrangements and uncoating; application of this knowledge for the design of vaccines, antiviral drugs, biomaterials and modified nanoparticles for biomedical or bionanotechnological uses.
Some recent results: i) The combined use of atomic force microscopy (AFM) and electron microscopy allowed us to experimentally determine for the first time the reversible pathway and intermediates of assembly and disassembly of a structurally simple spherical virus (Fig.1). ii) Using mutational analysis and the determination of mechanical properties of virus particles by AFM we have discovered a relationship between genetic changes that alter the mechanical stiffness of virus particles and changes in the propensity of the latter to undergo conformational changes related to the infection process (Fig.2). iii) we have characterized the structure, dynamics and mechanical properties of a bidimensional nanocoating made by self-assembly of the HIV capsid protein on a solid matrix. These and other studies by our group have implications for a better understanding of processes essential for viral infection, the design of new antivirals that may inhibit these processes, and the development of nanoparticles and bidimensional biomaterials with improved mechanical properties for applications such as targeted drug delivery or tissue regeneration.